Focus on five patients treated with cyclosporine up to 62 months.

CONCLUSION: Cyclosporine is an acceptable monotherapy for psoriasis in selected patients. The prompt discontinuation of treatment usually results in resolution of any eventual toxicity. PMID: 26822802 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26822802?dopt=Abstract

Source: Journal of Dermatological Treatment - February 16, 2016 Category: Dermatology Tags: J Dermatolog Treat Source Type: research